HOLX Relative Valuation
HOLX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HOLX is overvalued; if below, it's undervalued.
Historical Valuation
Hologic Inc (HOLX) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.86 is considered Undervalued compared with the five-year average of 17.34. The fair price of Hologic Inc (HOLX) is between 65.20 to 91.77 according to relative valuation methord. Compared to the current price of 63.26 USD , Hologic Inc is Undervalued By 2.98%.
Relative Value
Fair Zone
65.20-91.77
Current Price：63.26
2.98%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.07
P/B
Median3y
3.53
Median5y
4.17
7.06
FCF Yield
Median3y
6.94
Median5y
7.88
Competitors Valuation Multiple
The average P/S ratio for HOLX's competitors is 3.39, providing a benchmark for relative valuation. Hologic Inc Corp (HOLX) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -1.23%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Hologic Inc (HOLX) currently overvalued or undervalued?
What is Hologic Inc (HOLX) fair value?
How does HOLX's valuation metrics compare to the industry average?
What is the current P/B ratio for Hologic Inc (HOLX) as of Jul 17 2025?
What is the current FCF Yield for Hologic Inc (HOLX) as of Jul 17 2025?
What is the current Forward P/E ratio for Hologic Inc (HOLX) as of Jul 17 2025?